BioForce Nanosciences Holdings Inc
BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It also sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online at www… Read more
BioForce Nanosciences Holdings Inc (BFNH) - Net Assets
Latest net assets as of September 2025: $-499.94K USD
Based on the latest financial reports, BioForce Nanosciences Holdings Inc (BFNH) has net assets worth $-499.94K USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($784.00) and total liabilities ($500.72K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-499.94K |
| % of Total Assets | -63767.6% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | -13550.95% |
| Growth Volatility | 1089.57 |
BioForce Nanosciences Holdings Inc - Net Assets Trend (2002–2024)
This chart illustrates how BioForce Nanosciences Holdings Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for BioForce Nanosciences Holdings Inc (2002–2024)
The table below shows the annual net assets of BioForce Nanosciences Holdings Inc from 2002 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-2.30 Million | -26.51% |
| 2023-12-31 | $-1.82 Million | -35.03% |
| 2022-12-31 | $-1.35 Million | -56.32% |
| 2021-12-31 | $-861.86K | -139.47% |
| 2020-12-31 | $-359.91K | -860.78% |
| 2019-12-31 | $47.31K | +58.73% |
| 2018-12-31 | $29.80K | +263.37% |
| 2017-12-31 | $8.20K | +258.95% |
| 2016-12-31 | $2.29K | -86.65% |
| 2015-12-31 | $17.11K | -11.85% |
| 2014-12-31 | $19.41K | -11.41% |
| 2013-12-31 | $21.91K | -25.49% |
| 2012-12-31 | $29.41K | -98.68% |
| 2008-12-31 | $2.23 Million | 0.00% |
| 2007-12-31 | $2.23 Million | -43.36% |
| 2006-12-31 | $3.94 Million | +4211.53% |
| 2005-12-31 | $91.43K | -79.12% |
| 2004-12-31 | $437.88K | +77.53% |
| 2003-12-31 | $246.65K | -82.87% |
| 2002-12-31 | $1.44 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to BioForce Nanosciences Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 15984430300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $29.27K | % |
| Other Components | $158.79 Million | % |
| Total Equity | $-2.30 Million | 100.00% |
BioForce Nanosciences Holdings Inc Competitors by Market Cap
The table below lists competitors of BioForce Nanosciences Holdings Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Park Street A/S
CO:PARKST-A
|
$4.83 Million |
|
Afcon Holdings Ltd
TA:AFHL
|
$4.83 Million |
|
Garibaldi Resources Corp
PINK:GGIFF
|
$4.83 Million |
|
Austral Gold Limited
PINK:AGLDF
|
$4.83 Million |
|
Zenith Steel Pipes & Industries Limited
NSE:ZENITHSTL
|
$4.82 Million |
|
AcouSort AB
ST:ACOU
|
$4.82 Million |
|
Thai Wire Products Public Company Limited
BK:TWP
|
$4.82 Million |
|
Finlay Minerals Ltd
OTCQB:FYMNF
|
$4.82 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BioForce Nanosciences Holdings Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -1,819,230 to -2,301,592, a change of -482,362.
- Net loss of 490,437 reduced equity.
- New share issuances of 8,075 increased equity.
- Other factors decreased equity by 0.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-490.44K | -21.31% |
| Share Issuances | $8.07K | +0.35% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares BioForce Nanosciences Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | $0.76 | $0.57 | x |
| 2003-12-31 | $0.13 | $0.57 | x |
| 2004-12-31 | $0.20 | $0.57 | x |
| 2005-12-31 | $0.04 | $0.57 | x |
| 2006-12-31 | $0.87 | $0.57 | x |
| 2007-12-31 | $0.09 | $0.57 | x |
| 2008-12-31 | $0.46 | $0.57 | x |
| 2012-12-31 | $0.00 | $0.57 | x |
| 2013-12-31 | $0.00 | $0.57 | x |
| 2014-12-31 | $0.00 | $0.57 | x |
| 2015-12-31 | $0.00 | $0.57 | x |
| 2016-12-31 | $0.00 | $0.57 | x |
| 2017-12-31 | $0.00 | $0.57 | x |
| 2018-12-31 | $0.00 | $0.57 | x |
| 2019-12-31 | $0.00 | $0.57 | x |
| 2020-12-31 | $-0.02 | $0.57 | x |
| 2021-12-31 | $-0.03 | $0.57 | x |
| 2022-12-31 | $-0.05 | $0.57 | x |
| 2023-12-31 | $-0.06 | $0.57 | x |
| 2024-12-31 | $-0.08 | $0.57 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently BioForce Nanosciences Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-96.81%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | -57.99% | -119.43% | 0.42x | 1.16x | $-978.91K |
| 2003 | -520.59% | -158.75% | 0.98x | 3.35x | $-1.31 Million |
| 2004 | -270.91% | -862.17% | 0.11x | 2.84x | $-1.23 Million |
| 2005 | -21.02% | -13.75% | 0.10x | 15.56x | $-28.36K |
| 2006 | -100.82% | -957.41% | 0.08x | 1.28x | $-4.37 Million |
| 2007 | -172.62% | -342.59% | 0.36x | 1.38x | $-4.08 Million |
| 2008 | -172.62% | -342.59% | 0.36x | 1.38x | $-4.08 Million |
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $-3.88K |
| 2013 | 100.00% | 82.96% | 1.21x | 1.00x | $19.94K |
| 2014 | -12.88% | 0.00% | 0.00x | 1.03x | $-4.44K |
| 2015 | 0.00% | -41.15% | 0.34x | 0.00x | $-880.40 |
| 2016 | 0.00% | -30.30% | 0.50x | 0.00x | $-405.40 |
| 2017 | -381.14% | -694.69% | 0.22x | 2.55x | $-32.08K |
| 2018 | -227.28% | -415.32% | 0.46x | 1.18x | $-70.72K |
| 2019 | -98.37% | -261.82% | 0.30x | 1.24x | $-51.27K |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-158.37 Million |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $-415.77K |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-350.79K |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-290.03K |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $-260.28K |
Industry Comparison
This section compares BioForce Nanosciences Holdings Inc's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $5,681,533,529
- Average return on equity (ROE) among peers: 0.04%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BioForce Nanosciences Holdings Inc (BFNH) | $-499.94K | -57.99% | N/A | $4.82 Million |
| Above Food Ingredients Inc. Common Stock (ABVE) | $30.90K | -3.31% | 7.66x | $18.76 Million |
| The a2 Milk Company Limited (ACOPF) | $7.27 Million | -30.19% | 0.14x | $3.91 Billion |
| Ayujoy Herbals Ltd (AJOY) | $22.20 Million | 29.29% | 0.00x | $95.71 |
| Alfa S.A.B. de C.V (ALFFF) | $53.35 Billion | 7.36% | 3.80x | $2.16 Billion |
| Amincor Inc (AMNCB) | $34.44 Million | -63.76% | 0.81x | $2.24K |
| Armanino Foods New (AMNF) | $21.40 Million | 30.30% | 0.33x | $72.33K |
| Amira Nature Foods Ltd (ANFIF) | $303.22 Million | 8.27% | 0.89x | $128.79 |
| AAK AB (publ.) (ARHUF) | $2.44 Billion | 12.85% | 2.63x | $5.07 Billion |
| Artisan Consumer Goods Inc (ARRT) | $-326.75K | 0.00% | 0.00x | $279.39K |
| ARYZTA AG (ARZTF) | $632.10 Million | 9.58% | 2.04x | $53.13 Million |